If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this ...
This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...
Hypertension symptoms: Most people with hypertension have vague symptoms like headaches, dizziness, breathlessness, nosebleeds, or even blurred vision (Image: Pexels) High blood pressure, or ...
If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.
Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...
Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood of worsening disease when added within ...
The use of GLP-1 RAs was associated with lower medication use, reduced headaches, visual disturbances or blindness, and papilledema. HealthDay News — For patients with idiopathic intracranial ...
MONDAY, July 21, 2025 (HealthDay News) -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved ...
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results